This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Gemalto M2M Solution Enables Next-Generation MHealth

AMSTERDAM, May 20, 2014 (GLOBE NEWSWIRE) -- Gemalto (Euronext NL 0000400653 GTO), the world leader in digital security, announces its Cinterion ® M2M technology is providing wireless cellular connectivity for the next-generation of pill dispensers. Developed by MedMinder and wirelessly enabled by Gemalto, the advanced mHealth device for convenient patient use tracks medication intake, sends medical alerts, orders refills and improves prescription compliance. The new, innovative dispenser enhances communication between patients and caregivers, improving the overall well-being, independence and peace of mind for patients.

MedMinder's smart pill dispensers, equipped with Gemalto's advanced M2M module, monitor medication usage and send data from the pill box over wireless networks to a central server. Physicians and caregivers can log on to MedMinder's secure web interface to observe medication adherence and manage changes when necessary. Gemalto's 20 years' experience in security combined with its M2M technology ensures this personal information is accessed only by authorized individuals. Continued success of the mHealth industry relies on secure data protection, in which Gemalto is playing a key role.

The solution provides an audio alarm to alert the patient when medication should be taken. Caregivers also receive alerts if scheduled doses are missed giving caregivers the ability to offer real-time support for an enhanced level of medical care. The patient can chose their preferred method of communication as the connectivity enables the pill dispenser to send reminders via text message, email or a phone call. In addition, MedMinder Medication Dispenser has Medical Alert embedded for two way voice channel with the patient's monitoring center in case of an emergency.

"The Gemalto M2M solution allows for secure connectivity that provides 24/7 automated communication between the pill box, patient, doctor and medical alert monitoring center depending on the urgency of the situation" said Eran Shavelsky, CEO of MedMinder. "The technology also offers flexibility and cost-effectiveness for our devices with the option to add new features and expand capabilities in the future without having to redesign the device."

"The Gemalto Cinterion PHS8 module is the slimmest M2M module on the market, and ideally suited to MedMinder's compact solution," said Paul Kobos, Head of M2M Sales for Gemalto North America. "With an aging population and growing need for chronic care management, Gemalto M2M technology truly impacts patients' day-to-day care while protecting data and can be seamlessly integrated into healthcare IT systems."

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the world leader in digital security with 2013 annual revenues of €2.4 billion and more than 12,000 employees operating out of 85 offices and 25 research and software development centers, located in 44 countries.

We are at the heart of the rapidly evolving digital society. Billions of people worldwide increasingly want the freedom to communicate, travel, shop, bank, entertain and work – anytime, everywhere – in ways that are enjoyable and safe. Gemalto delivers on their expanding needs for personal mobile services, payment security, authenticated cloud access, identity and privacy protection, eHealthcare and eGovernment efficiency, convenient ticketing and dependable machine-to-machine (M2M) applications. We develop secure embedded software and secure products which we design and personalize. Our platforms and services manage these products, the confidential data they contain and the trusted end-user services made possible.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.87 +0.92 0.05%
NASDAQ 4,465.1050 +22.4070 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs